Результаты транскатетерного протезирования митрального клапана

Митральная недостаточность является самой распространенной клапанной патологией. Почти у половины пациентов стандартное протезирование митрального клапана с использованием искусственного кровообращения не может быть выполнено в связи с высоким риском развития осложнений, обусловленным тяжестью порока либо наличием сопутствующих заболеваний.
В последние годы для данной категории пациентов предложена методика транскатетерного протезирования митрального клапана. К настоящему вре­мени известно о ряде транскатетерных протезов для имплантации в нативный митральный клапан, находящихся на стадии доклинических либо клинических испытаний. В данной статье проанализированы результаты клинического при­
менения протезов для транскатетерного протезирования митрального клапана.

1. Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016;102: 75–85. doi: 10.1136/heartjnl-2014-307020.

2. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–91. doi: 10.1093/eurheartj/ehx391.

3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-8.

4. Kim WK, Hamm CW. Transcatheter aortic valve implantation in Germany. Clin Res Cardiol. 2018;107:81-7. doi: 10.1007/s00392-018-1297-0. doi: 1 10.1007/s00392-018-1297-0.

5. Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674–81. doi: 10.1067/mtc.2001.117277.

6. Regueiro A, Granada JF, Dagenais F, et al. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69:2175-92. doi: 10.1016/j.jacc.2017.02.045.

7. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252-89. doi: 10.1016/j.jacc.2017.03.011.

8. Sorajja P, Maisano F. Percutaneous treatment for native mitral regurgitation. Progress in Cardiovascular Diseases. 2017;60(3):405-14. doi: 10.1016/j.pcad.2017.11.003

9. Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-Year results of EVEREST II. J Am Coll Cardiol. 2015;66(25):2844-54. doi: 10.1016/j.jacc.2015.10.018.

10. Журавлева И. Ю., Богачев-Прокофьев А. В., Демидов Д. П., и др. Транскатетерное протезирование митрального клапана: современное состояние проблемы. Кардиология. 2017;58(8):53–57. doi: 10.18087/cardio.2017.8.10018.

11. Paradis JM, Del Trigo M, Puri R, et al. Transcatheter valve‐in‐valve and valve‐in‐ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol. 2015;66(18):2019–2037. doi: 10.1016/j.jacc.2015.09.015.

12. Guerrero M, Dvir D, Himbert D, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9:1361-71. doi: 10.1016/j.jcin.2016.04.022.

13. Sondergaard L, De Backer O, Franzen OW, et al. First-in-human case of transfemoral CardiAQ mitral valve implantation. Circ Cardiovasc Interv. 2015;8:e002135.doi: 10.1161/CIRCINTERVENTIONS.115.002135.

14. Moat NE, Duncan A, Quarto C. Transcatheter mitral valve implantation: Tendyne. EuroIntervention. 2016;12:75–7. doi: 10.4244/EIJV12SYA20.

15. Cheung A, Banai S. Transcatheter mitral valve implantation: Tiara. EuroIntervention. 2016;12;70–2. doi: 10.4244/ EIJV12SYA18.

16. Bapat V, Lim ZY, Boix R, et al. The Edwards Fortis transcatheter mitral valve implantation system. EuroIntervention. 2015;11:73–5. doi: 10.4244/EIJV11SWA21.

17. Meredith I, Bapat V, Morriss J, et al. Intrepid transcatheter mitral valve replacement system: technical and product description. EuroIntervention. 2016;12:78–80. doi: 10.4244/EIJV12SYA21.

18. Navia JL, Baeza C, Maluenda G, et al. Transcatheter mitral valve replacement with the NaviGate stent in a preclinical model. EuroIntervention. 2017;13:1401-9. doi: 10.4244/EIJ-D-17-00210.

19. Abdelghani M, Onuma Y, Zeng Y, et al. The Sino Medical AccuFit transcatheter mitral valve implantation system. EuroIntervention. 2015;11:84–5. doi: 10.4244/EIJV11SWA26.

20. Журавлева И.Ю., Нуштаев Д.В., Тимченко Т.В., и др. Модель устройства для транскатетерной замены митрального биопротеза при его дисфункции. Cовременные технологии в медицине. 2017;9(3):7–14. doi: 10.17691/stm2017.9.3.0.

21. Богачев-Прокофьев А.В., Журавлева И.Ю., Шарифулин Р.М., и др. Имплантация in vitro первого отечественного транскатетерного протеза в нативный митральный клапан. Патология кровообращения и кардиохирургия. 2018;22(1):22-8. doi: 10.21688-1681-3472-2018-1-22-28.

22. Loger K, Pokorny S, Schaller T, et al. Novel stent design for transcatheter mitral valve implantation. Interact Cardiovasc Thorac Surg. 2018;26(2):190-5. doi: 10.1093/icvts/ivx289.

23. Bergsland J, Mirtaheri P, Hiorth N, et al. Review of the endovascular approach to mitral valve disease. Minimally Invasive Therapy. 2015;24:282–8. doi: 10.3109/13645706.2015.1065891.

24. Coylewright M, Cabalka AK, Malouf JA, et al. Percutaneous mitral valve replacement using a transvenous, transseptal approach: transvenous mitral valve replacement. JACC Cardiovasc Interv. 2015;8(6):850–7. doi: 10.1016/j.jcin.2015.01.028.

25. Sondergaard L, Brooks M, Ihlemann N,et al. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg. 2015;48(6):873-7. doi: 10.1093/ejcts/ezu546.

26. Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71:12-21. doi: 10.1016/j.jacc.2017.10.061.

27. Ussia GP, Cammalleri V, Mehta JL, et al. Transcatheter mitral valve replacement with a novel self-expandable prosthesis: single institutional experience procedural outcomes and follow-up. J Cardiovasc Med (Hagerstown). 2017;18(6):415-4. doi:10.2459/JCM.0000000000000513.

28. Barbanti M, Tamburino C. Transcatheter mitral valve implantation: CardiAQ. EuroIntervention. 2016;12:73–4. doi: 10.4244/EIJV12SYA19.

29. Banai S, Jolicoeur EM, Schwartz M, et al. Tiara: a novel catheter-based mitral valve bioprosthesis: initial experiments and short-term pre-clinical results. J Am Coll Cardiol. 2012;60:1430-1. doi: 10.1016/j.jacc.2012.05.047.

30. Verheye S, Cheung A, Leon M, et al. The Tiara transcatheter mitral valve implantation system. EuroIntervention 2015;11:71–2. doi: 10.4244/EIJV11SWA20.

31. Quarto C, Davies S, Duncan A, et al. Trans-catheter mitral valve implantation: 30-day outcome of first-in-man experience with an apically tethered device. Innovations (Phila) 2016; 11:174–8. doi: 10.1097/IMI.0000000000000278.

32. Duncan A, Daqa A, Yeh J, et al. Transcatheter mitral valve replacement: long-term outcomes of first-in-man experience with an apically tethered device – a case seres from a single centre. EuroIntervention. 2017;13:1047-57. doi:10.4244/EIJ-D-17-00154.

33. Muller DW, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69:381-91. doi: 10.1016/j.jacc.2016.10.068.

34. Barbanti M, Piazza N, Mangiafico S, et al. Transcatheter mitral valve implantation using the HighLife system. JACC Cardiovasc Interv. 2017;10:1662-70. doi:10.1016/j.jcin.2017.06.046.

35. Lange R, Piazza N. HighLife transcatheter mitral valve replacement. EuroIntervention. 2016;12:81-3. doi:10.4244/EIJV12SYA22.

36. Abdul-Jawad Altisent O, Dumont E, Dagenais F, et al. J. Transcatheter mitral valve implantation with the FORTIS device: Insights into the evaluation of device success. JACC: Cardiovasc Interv. 2015;8(7):994–5. doi.org/10.1016/j.jcin.2015.01.036.

37. Abdul-Jawad Altisent O, Dumont E, Dagenais F, et al. J. Initial experience of transcatheter mitral valve replacement with a novel transcatheter mitral valve: procedural and 6-month follow-up results. J Am Coll Cardiol. 2015;66(9):1011-9. doi: 10.1016/j.jacc.2015.06.1322.

38. Edwards Life Sciences, Corp. Edwards pauses enrollment in early stage mitral program. Edwards Lifesciences Corp. May 19, 2016. http:// www.edwards.com/fr/newsroom/Pages/ShowPR. aspx?PageGuid1⁄4%7B61d40c10-d690-45fa-b541- ab1f4806b975%7D ( March 1, 2017).

39. Regueiro A, Ye J, Fam N, et al. 2-Year Outcomes After Transcatheter Mitral Valve Replacement. JACC Cardiovasc Interv. 2017;10(16):1671-8. doi: 10.1016/j.jcin.2017.05.032.

40. Cheung A, Webb J, Verheye S, et al. Short- term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64:1814–9. doi: 10.1016/j.jacc.2014.06.1208.